News & Articles

Cosmetic products are substances or mixtures designed for use on the external parts of the body, such as the skin, hair, nails, lips, and teeth, for the purpose of cleansing, perfuming, protecting, or enhancing appearance. In Singapore, all cosmetic products must comply with safety regulations and require a cosmetic product notification before they can be […]

At the current moment, Health Supplements are not subjected to registration prior to importation. Notification is on a voluntary basis. There may be advantage for you to execute the notification of the health supplements from a commercial perspective and it is always to be pro-active to adapt to the existing regulations rather than to rush […]

A generic product must have the same qualitative and quantitative composition in active ingredients and be of the same pharmaceutical form as a currently registered product in Singapore and shown to be bioequivalent to Singapore Reference Product (SRP). A marketing authorization application for a generic product fall under the application category of GDA-1 and GDA-2 […]

A Marketing Authorization Holder (MAH) is a local company that is assigned by the Manufacturer to be in charge of all licensing matters.

Regulatory intelligence as defined in TRC’s understanding is market research on regulations with the following objectives in mind:  To obtain the most accurate information concerning pathway , application type , requirements , timelines, and fees of the pharmaceutical or medical products to be registered  Impact of a certain regulations on existing pipeline of products  The feasibility of using existing dossier to apply for marketing authorization in the territory of interest  Get a framework of how a certain product is regulated in a certain market as a global regulatory strategy  To examine a potential question e.g a lack of certain documents such as not having PIC/S GMP or not meeting certain criteria e,g not having Zone IVb stability data which is essential in ASEAN countries or not having prior approval in reference agencies of the territory could be critical for registration in the case of biosimilars

Due to the nature of the healthcare and pharmaceutical industry, products and services produced for medical use need to undergo strict processes and meet certain requirements before they are allowed on the market. As the industry continues to grow and evolve, ensuring safety, efficacy, and quality through regulatory affairs management becomes even more crucial in […]